ILC3 is the most abundant type of ILCs in the intestines and plays a protective role in IBD in mammals by promoting epithelial cell proliferation and survival, as well as enhancing intestinal barrier function through the production of IL-22 (Buonocore et al., 2010; Aparicio-Domingo et al., 2015). This evidence concerns the gene IL22 and inflammatory bowel disease.